1. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005;58:175-89.
2. Cizza G, Ravn P, Chrousos G. Depression, a major risk factor for osteoporosis? Trends Endocrinol Metab 2001;12:198-203.
3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distribution of DSM-IV in the national comorbidity survey replication. Arch Gent Psychiatry 2005;62:593-602.
4. Schweiger U, Deuschle M, Körner A, Lammers CH, Schmider J, Gotthardt U, et al. Low bone mineral density in patients with major depression. Am J Psychiatry 1994;151: 1691-3.
5. Kavuncu V, Kuloglu M, Kaya A, Sahin S, Atmaca M, Firidin B. Bone metabolism and bone mineral density in premenopausal women with mild depression. Yonsei Med J 2002;43:101-8.
6. Mezuk B, Eaton WW, Golden SH. Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos Int 2008:19:1-12.
7. Kul Panza E, Güven Z, Akyüz G, Ofluoğlu D. Osteoporotik ve Osteopenik Hastalarda Depresyon ve Yaşam Tarzı ile İlişkisi. Osteoporoz Dünyasından 2004;10:29-31.
8. Schweiger U, Weber B, Deuschle M, Heuser I. Lumbar bone mineral density in patients with major depression. Am J Psychiatry 2000;157:118-20.
9. Forsén L, Meyer HE, Søgaard AJ, Naess S, Schei B, Edna TH. Mental distress and risk of hip fracture: do broken hearts lead to broken bones? J Epidemiol Community Health 1999;53:343-7.
10. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS. Depression, falls and risk of fracture in older women. Arch Int Med 1999;159: 484-90.
11. Soogard A, Joakimsen R, Tverdal A, et al. Long-term mental distress, bone mineral density and non-vertebral fractures: the Toronto Study. Osteoporos Int 2005;16:2887-97.
12. Mussolino M. Depression and hip fracture: the NHANES I Epidemiologic followup study. Public Health Rep 2005;53:343-7.
13. Greendale GA, Unger JB, Rowe JW, Seeman TE. The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur Studies. J Am Geriatr Soc 1999;47:799-803.
14. Korpelainen R, Korpelainen J, Heikkinen J, Väänänen K, Keinänen-Kiukaanniemi S. Lifelong risk factors for osteoporosis and fracture in elderly women with low body mass index-a population based syudy. Bone 2006;39:385-91.
15. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA. Urinary free cortisol excretion in depression. Psychol Med 1976;6:43-50.
16. Licinio J, Wong M. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines mdulate the biological substrate of depressive symptoms, regulate stress-response systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999;4:317-27.
17. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K. Relationship of c-reactive protein and bone mineral density in community dwelling elde rly females. J Natl Med Assoc 2005;128:127-37.
18. Raisz L. Physiology and pathophysiology of bone remodeling. Clin Chem 1999;48:1353-58.
19. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266-74.
20. Altindag O, Altindag A, Asoglu M, Gunes M, Soran N, Deveci Z. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract 2007;61:416-20.
21. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90:2522-30.
22. Yirmiya R, Goshen I, Bajayo A, Kreisel T, Feldman S, Tam J, et al. Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci USA 2006;103:16876-81.
23. Kapoor D, Jones T. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 2005;152:491-9.
24. Chakkalakal D. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005;9:2077-90.
25. Warden SJ, Hassett SM, Bond JL, Rydberg J, Grogg JD, Hilles EL, et al. Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone 2010;46:985-92.
26. Rizzoli R, Eisman JA, Norquist J, Ljunggren O, Krishnarajah G, Lim SK, et al. Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract 2006;60:1013-9.
27. Sert M, Tetiker T, Kirim S, Soyupak S, Canataroğlu A, Koçak M. Type 2 diabetes mellitus and osteopenia: is there any association? Acta Diabetol 2003;40:105-8.
28. Vestergaard P, Reynmark L, Mosekilde L. Relative fracture risk inpatients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005;48:1292-9.
29. Vestergaard P. Epilepsy, osteoporosis and fracture risk-a meta-analysis. Acta Neurol Scand 2005;112;277-86.
30. Héla S, Nihel M, Faten L, Monia F, Jalel B, Azza F, Slaheddine S. Osteoporosis and Crohn’s disease J Bone Joint Surg 2005;72:403-7.
31. Romas E. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Best Pract Res Clin Rheum 2005;19:1065-79.
32. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P. Bone mineral density in women with depression. NEJM 1996;335:1176-81.
33. Wong SY, Lau EM, Lynn H, Leung PC, Woo J, Cummings SR, et al. Depression and bone mineral density: is there a relatonship in elderly Asian men? Results from Mr Os (Hong Kong). Osteoporos Int 2005;16:610-5.
34. Coelho R, Silva C, Maia A, et al. Bone mineral density and depression: a community study of women. J Psychosom Res 1999; 46: 29-35.
35. Yazici KM, Akinci A, Sütçü A, Ozçakar L. Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 2003;117:271-5.
36. Kinoshita T, Kobayashi S, Ebara S, Yoshimura Y, Horiuchi H, Tsutsumimoto T, et al. Phosphodiesterase inhibitors pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. Bone 2000;27:811-7.
37. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005;146:685-93.
38. Bonnet N, Bernard P, Beaupied H, Bizot JC, Trovero F, Courteix D, et al. Various effects of antidepressant drugs on bone microarchitecture, mechanical properties and bone remodeling. Toxicol Applied Pharmacol 2007;221:111-8.
39. Takkouche B, Montes-Martínez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Safety 2007;30:171-84.
40. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of fracture. Am J Epidemiol 2003;158:77-84.
41. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998;351:1303-7.
42. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, et al Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007;167:188-94.
43. Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: A population-based analysis. J Clin Psychopharmacol 2008;28:384-91.
44. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics and sedatives and risk of fractures: Effects of half-life. Calcified Tissue International 2008;82:34-44.
45. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med 2007;167(21):2329-36.
46. Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am J Psychiatry 2005;162:168-74.
47. Bainbridge KE, Sowers M, Lin X, Harlow SD. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 2004;15:439-46.